Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03931330 · ClinicalTrials.gov registry record · NA
Does Improving Vagal Tone Increase Mitochondrial Bioenergetics
A NA study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03931330 is a NA study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 8 participants.
The verdict
NCT03931330, a NA study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
This study evaluates the effect of auricular neurostimulation on mitochondrial bioenergetics and inflammation through vagal nerve modulation via non-invasive percutaneous electrical nerve field stimulator in children with functional gastrointestinal disorders.
Interventions
- DEVICE Percutaneous neurostimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2019-02-06 |
| Est. Completion | 2019-09-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03931330
The ClinicalTrials.gov registry entry for NCT03931330 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Percutaneous neurostimulation is the first listed.
NCT03931330 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03931330 about?
NCT03931330 is a clinical study titled "Does Improving Vagal Tone Increase Mitochondrial Bioenergetics". This study evaluates the effect of auricular neurostimulation on mitochondrial bioenergetics and inflammation through vagal nerve modulation via non-invasive percutaneous electrical nerve field stimulator in children with functional gastrointestinal disorders.
What is the current status of trial NCT03931330?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2019-02-06. Estimated completion is 2019-09-24.
What interventions are being tested in trial NCT03931330?
The interventions under investigation include: Percutaneous neurostimulation (DEVICE).
Who is sponsoring clinical trial NCT03931330?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.